We are live on ! Find out more
ADAP

Adaptimmune Therapeutics

Delisted

ADAP was delisted on the 27th of October, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
MCMC
1
Matrix Capital Management Company
New Hampshire
$30.4M
Baillie Gifford & Co
2
Baillie Gifford & Co
United Kingdom
$13.4M -$24.1K -28,726 -0.2%
NMC
3
NEA Management Company
Maryland
$13.3M
BBA
4
Baker Bros. Advisors
New York
$8.56M
LFCM
5
Long Focus Capital Management
Puerto Rico
$8.55M +$2.64M +3,150,630 +40%
PHS
6
PFM Health Sciences
California
$8.13M +$1.73M +2,065,893 +25%
MAM
7
MPM Asset Management
Massachusetts
$4.9M
TCM
8
Tang Capital Management
California
$4.03M +$235K +279,716 +6%
MB
9
MPM BioImpact
Massachusetts
$3.97M
Bank of America
10
Bank of America
North Carolina
$3.66M -$1.09K -1,294 -0%
Citadel Advisors
11
Citadel Advisors
Florida
$2.77M +$151K +179,476 +5%
RSCM
12
Rock Springs Capital Management
Maryland
$2.17M
Morgan Stanley
13
Morgan Stanley
New York
$1.6M -$21.7K -25,826 -1%
Fidelity Investments
14
Fidelity Investments
Massachusetts
$1.35M -$377 -449 -0%
SP
15
Syncona Portfolio
Guernsey
$1.07M
BlackRock
16
BlackRock
New York
$988K +$87.3K +103,996 +9%
AG
17
Artal Group
Luxembourg
$884K
JP Morgan Chase
18
JP Morgan Chase
New York
$805K -$230K -273,497 -21%
Renaissance Technologies
19
Renaissance Technologies
New York
$802K -$402K -478,515 -32%
RG
20
Redmile Group
California
$558K
Citigroup
21
Citigroup
New York
$454K +$66 +79 +0%
AI
22
Acuitas Investments
Washington
$374K +$403K +479,764 New
RG
23
Rathbones Group
United Kingdom
$338K
DCM
24
DAFNA Capital Management
California
$274K
KCFA
25
Key Client Fiduciary Advisors
New Jersey
$247K -$10.8K -12,830 -4%